GALWAY, Ireland, July 8, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the appointment of Chad Spooner as chief financial officer (CFO) of MiniMed, in advance of its intended separation into a standalone, public company. Effective July 14, 2025, Chad will be responsible for overseeing the Finance function for Medtronic Diabetes and supporting initiatives aimed at accelerating profitable growth and delivering shareholder value as it prepares to beco ...

SOMERSET, N.J., July 02, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO) ("CareCloud" or the "Company"), a leader in AI-driven healthcare technology solutions for medical practices and health systems nationwide, today announced that it has been added to the Russell Microcap® Index, effective at the open of U.S. markets on June 30, 2025, as part of the Russell indexes' annual reconstitution based on market capitalization, public float, and related criteria. The inclusion underscores growing re ...

Core Points - CareCloud has surpassed the accelerated filer threshold with a public float of $85.1 million as of June 30, 2025, triggering new compliance requirements under SEC regulations [1] - The achievement is seen as a validation of CareCloud's growth trajectory and investor confidence, with a commitment to compliance and corporate governance emphasized by the Co-CEO [2] - The current audit firm cannot perform the required ICFR attestation, necessitating a change in auditors to ensure compliance [2] - CareCloud has initiated a process to engage a new audit firm capable of fulfilling the necessary services for fiscal year 2025 [3] Company Overview - CareCloud specializes in AI-driven healthcare technology solutions, helping over 40,000 providers enhance patient care while reducing administrative burdens and operating costs [4]

Core Viewpoint - Syra Health Corp. has been recommended for contract negotiations to implement Indiana's Child Mental Health Wraparound Access Site, valued at $5.8 million over three years, with a potential one-year extension [1][2]. Company Overview - Syra Health is a healthcare technology company focused on improving health through innovative technology products and services, particularly in mental health, population health, and healthcare workforce [4]. - The company emphasizes prevention, access, and affordability in its healthcare solutions, aiming to advance healthcare nationwide and globally [4]. Contract Details - The contract with the Indiana Department of Administration involves Syra Health serving as the statewide access point for families and providers in the Child Mental Health Wraparound program [3]. - Syra Health will subcontract 23.5% of the total contract value to other Indiana-based companies, indicating a commitment to local partnerships [1]. Strategic Importance - This initiative is part of Indiana's broader strategy to enhance care coordination and improve mental health outcomes for children across the state [3]. - Syra Health has a proven track record of executing complex health initiatives for state and local governments, showcasing its capability in delivering comprehensive health solutions [2].

NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Veri Medtech Holdings, Inc. (Stock Ticker Symbol: “VRHI”) ("Veri Medtech"), healthcare technology platform, announced today that $3,308,297 in revenue was generated during the first quarter of 2025, with an aggregate of up to $100 million in sales revenue generated since inception in 2017. For more information, please visit: www.VeriMedtech.com Additional Key Accomplishments: Retained PCAOB Auditor (in preparation for uplisting)Announced up to 400,000 Patients Mile ...

Revenue increase led by Population Health's 261% YoY ExpansionGross Margin Improves Substantially to 31.7%, up 14.6 Percentage Points YoYContinued Efficiency Gains Cut Q1 2025 Net Losses by Over Two Thirds Compared to Q1 2024A conference call will be held today, Thursday, May 8, at 9:00 am ETCARMEL, Ind., May 8, 2025 /PRNewswire/ -- Syra Health Corp. (OTCQB: SYRA) ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and ...

Core Insights - Veri Medtech has relaunched its Veriheal.com healthcare technology platform, enhancing its capabilities to connect patients and physicians [1][2] - The upgraded platform aims to solidify Veriheal's leadership in the healthcare technology market [2] - Veri Medtech Holdings is focused on providing alternative medicine, personalized diagnostics, and wellness medication on demand, leveraging telehealth and digital systems [3] Company Overview - Veri Medtech Holdings, Inc. is a publicly-traded healthcare technology company with the stock ticker symbol "VRHI" [3] - The company is strategically positioned for growth and actively seeks acquisitions to enhance its core capabilities in alternative medicine and wellness science [3] - Veri Medtech emphasizes innovation and patient-centric care, aiming to make personalized healthcare more accessible [3]

Core Insights - Acentra Health has been awarded a two-year contract worth $27.5 million by the California Department of Health Care Services to provide Level I screenings and Level II evaluations for serious mental illness as part of the PASRR program [1][2] - The company has a long-standing partnership with California Medicaid, having delivered PASRR services since 2015, and is recognized for its efficiency and effectiveness in this area [2][4] - California's PASRR program is the largest in the nation, with Acentra Health conducting approximately 233,000 initial screenings and 18,000 Level II evaluations annually, achieving turnaround times averaging fewer than two calendar days [4][5] Company Overview - Acentra Health specializes in technology and health solutions aimed at improving outcomes for government and commercial healthcare clients [1][7] - The company has over 30 years of experience in evaluating medical necessity for Medicaid beneficiaries and provides a range of PASRR services, including screenings, evaluations, and IT systems [6][7] - Acentra Health has expanded its PASRR portfolio to eight states, recently adding Kansas and Washington, indicating growth and increased market presence [5]

NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- Veri Medtech Holdings, Inc. (OTC Markets: (“VRHI”) ("Veri Medtech") announced today that it has retained Salberg & Company, P.A., as its PCAOB auditor, in furtherance of the uplisting process. For more information, please visit: http://www.salbergco.com. "Veri Medtech (VRHI) continues to execute on its mission to be the premier provider of healthcare technology services and products worldwide. Retaining Salberg & Company is an important strategic next step in the ...

Core Viewpoint - Clover Health Investments, Corp. announces that Lee A. Shapiro will not seek reelection to the Board of Directors due to new responsibilities as Chairman of the American Heart Association, with his term ending on June 10, 2025 [1][2]. Company Leadership Changes - Lee A. Shapiro has served on Clover Health's Board for four years and has contributed significantly to the company's mission [2]. - Andrew Toy, CEO of Clover Health, expresses gratitude for Shapiro's leadership and insights during his tenure [2]. - Vivek Garipalli, Executive Chairperson and founder, acknowledges Shapiro's unique contributions and announces that Thomas L. Tran will take over as Chairman of the Audit Committee and Nominating and Corporate Governance Committee effective June 10, 2025 [2][3]. Company Overview - Clover Health is a physician enablement technology company focused on providing access to quality healthcare for Medicare recipients, particularly seniors [4]. - The company utilizes its software platform, Clover Assistant, to aggregate patient data and improve health outcomes through early identification and management of chronic diseases [4]. - Clover Health offers PPO and HMO Medicare Advantage plans and extends its technology benefits to a broader audience through its subsidiary, Counterpart Health [4].